MIRA INFORM REPORT

 

 

Report Date :

09.04.2008

 

IDENTIFICATION DETAILS

 

Name :

EAST INDIA PHARMACEUTICAL WORKS LIMITED

 

 

Registered Office :

6 Little Russel Street, Kolkata – 700071, West Bengal

 

 

Country :

India

 

 

Financials (as on) :

31.03.2007

 

 

Date of Incorporation :

27.04.1936

 

 

Com. Reg. No.:

008598

 

 

CIN No.:

[Company Identification No.]

U24231WB1936PTC008598

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

CALE00068F

 

 

PAN No.:

[Permanent Account No.]

AAACE5779P

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer of Chemicals and Pharmaceuticals.

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 979724

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well – established and reputed company having fine track. Trade relations are fair. Available information indicates satisfactory financial responsibility of the company. General financial position is satisfactory. Payments are reported as usually correct and as per commitments.

 

The company can be considered good for normal business dealings at usual trade terms and conditions.

 

LOCATIONS

 

Registered Office/ Factory :

6 Little Russel Street, Nandalal Bose Sarani, Kolkata – 700071, West Bengal, India

Tel. No.:

91-33-22872262/ 3004/ 3007/ 3009/ 3041/ 22830709

Fax No.:

91-33-22873853/ 4289

E-Mail :

eipwl@cal.vsnl.net.in

dev200653@rediffmail.com

cs@eastindiapharma.org

Website :

http://www.eastindiapharma.org

 

 

Branch Office :

Andhra Pradesh

Industrial Plot No: 148, 149 and150 , IDA , Mallapur Hyderabad - 500 076

Telephones: 91-40-27178430

Tele Fax : 91-40-27178430

E. mail : eipwl@rediffmail.com

 

Karnataka

1, Mandi Yarappa Lane, Off. Silver Jubilee Park, P.B. No. 6612, Bangalore – 560 002      
Telephones : 91-80-2222978/ 2235424

Tele Fax : 91-80-2916411

 

Bihar

Durga Niwas, Bank Road, Patna – 800 001

Telephones: 91-612-2226266 / 2222839

Tele Fax : 91-612-226178

 

Delhi

3620 / 21, Netaji Subhas Marg, Daryaganj, New Delhi – 110 002

Telephones : 91-11-23262150 / 23283408

Tele Fax : 91-11-3273985

 

Haryana

105, The Mall, P.B. No. 63, Ambala Cantt. – 133 001

Phones : 91-171-22643280 / 22630277

 

Assam

Nilamoni Phukan Path, Christian Basti, Guwahati– 781 001

Telephones: 91-361-2340746 / 2340747 / 2600030

Email:eipwl_ghy@sify.com
Tele Fax: 91-361-543847


Orissa

Plot No. 1108, Holding No. 417/C/1, Vikash Nagar, Badambari, Cuttack – 753 012, Orissa

Phones : 91-671-2316782

 

Uttar Pradesh

Aishbagh, Lucknow – 226 004, Uttar Pradesh

Phones : 91-522-2692077 \ 2691704

Tele Fax :91-522-223404

 

West Bengal

19 / 1, Prince Rahimuddin Lane, Calcutta – 700 033

Phones: 91-33-24243198 \ 24248716

 

Burdwan Road, Siliguri – 734 405. District – Darjeeling, West Bengal

Phones : 91-353-2561679

 

Tamil Nadu

28, Second Line Beach, Chennai – 600 001, Tamil Nadu

Phones : 91-44-25231284 / 25225312

Tele Fax : 91-442-5231284

 

Kerala

Kenson Colony No. 9, Door No. XLI/470, (Old No. 39/120), Krishnaswamy Road. Ernakulam, Cochin – 682 035, Kerala

Phones :91-484-2351467

 

Madhaya Pradesh

746 / 1, Napier Town, Jabalpur – 482 001, Madhya Pradesh

Phones : 91-761-2314040 / 2504622

Tele Fax : 91-761-314040

 

Rajasthan

Bombay House Building, Mirza Ismail Road, Jaipur – 302 001, Rajasthan

Phones :91-141-2373292/2378341

 

 

Factory :

  • Behala Factory

 

  • Sarsuna Factory (Sarsuna is positioned at the southern precincts of kolkata

 

  • Durgapur Factory (170 kms From Kolkata)

 

 

DIRECTORS

 

Name :

Mr. Amit Kumar Sen

Designation :

Director

Address :

63 Jodhpur Park, Kolkata – 700068, West Bengal, India

Date of Birth/Age :

06.04.1943

Date of Appointment :

01.08.2002

 

 

Name :

Mr. Dipankar Dutta Gupta

Designation :

Managing Director

Address :

Government Housing Estate, Block 2, Flat No.15 28/1 Gariahat Road, Kolkata, West Bengal, India

Date of Birth/Age :

27.10.1950

Date of Appointment :

01.08.2002

 

 

Name :

Mr. Bhaskar Prasad Gupta

Designation :

Director

Address :

245 Jodhpur Park, Kolkata – 700068, West Bengal, India

Date of Birth/Age :

11.11.1940

Date of Appointment :

19.09.2003

Email :

bhaskargypta@vsnl.net

 

 

Name :

Mr. Probir Ray

Designation :

Director

Address :

10 Securin Roy Road, Behala, Kolkata – 700034, West Bengal, India

Date of Birth/Age :

19.04.1944

Date of Appointment :

25.07.2005

Email :

Ambical100@hotmail.com

 

 

Name :

Mr. Ram Narayan Mukherjee

Designation :

Director

Address :

4C, Nandy Street, Kolkata – 700029, West Bengal, India

Date of Birth/Age :

03.02.1927

Date of Appointment :

17.09.2004

 

 

Name :

Mr. Ranbir Mukherjee

Designation :

Director

Address :

16/20 Dover Lane, Kolkata – 700029, West Bengal, India

Date of Birth/Age :

03.12.1928

Date of Appointment :

17.09.2004

Email :

ranbirmukherji@yahoo.co.in

 

 

Name :

Mr. Samir Bhattacharya

Designation :

Director

Address :

Proressor Department of Zoology School of Lafe Science Visva BH Arati Shantiniketan BI Rbhun West, Bengal – 731235, India

Date of Birth/Age :

21.11.1942

Date of Appointment :

26.05.2005

Email :

smrbhattacharya@yahoo.com

 

 

Name :

Mrs. Saroj Kumar Gupta

Designation :

Director

Address :

4, Nrisingha Dutta Road, Kolkata – 700008, West Bengal, India

Date of Birth/Age :

05.12.1929

Date of Appointment :

16.09.2005

Email :

cancerwelfare@yahoo.co.in

 

 

Name :

Mrs. Subrata Das Gupta

Designation :

Director

Address :

11/1 Russa Road, Kolkata – 700033, West Bengal, India

Date of Birth/Age :

04.08.1934

Date of Appointment :

19.09.2003

 

 

Name :

Mrs. Suman Ghosh

Designation :

Director

Address :

EC 165 Salt Lake City, Sector – I, Kolkata – 700064, West Bengal, India

Date of Birth/Age :

12.12.1943

Date of Appointment :

17.09.2004

Email :

sgee@vsnl.com

 

 

Name :

Mr. Sukumar Bhattacharya

Designation :

Director

Address :

64/1/25 A Beigachia Road, Kolkata – 700037, West Bengal, India

Date of Birth/Age :

01.04.1923

Date of Appointment :

19.09.2003

 

 

Name :

Mrs. Usha Ranjan Ghatak

Designation :

Director

Address :

23 B, Naktala Lane, (DPP Road), Kolkata- 700047, West Bengal, India

Date of Birth/Age :

26.02.1931

Date of Appointment :

20.09.2002

 

 

Name :

Mr. Raban Sengupta

Designation :

Director

Address :

72, Jodhpur Park, Flat No.4A, Kolkata – 700068, West Bengal, India

Date of Birth/Age :

05.12.1943

Date of Appointment :

22.05.2007

Email :

rabansengupta@yahoo.co.in

 

 

Name :

Mr. Samir Bhattacharya

Designation :

Director

Address :

Diganta Palli, Santiniketan 731235, West Bengal, India

Date of Birth/Age :

21.11.1942

Date of Appointment :

26.05.2005

Email :

Smrbhattacharya@yahoo.com

 

KEY EXECUTIVES

 

Name :

Mr. Nirjhar Mukhopadhyay

Designation :

Company Secretary

Address :

18 Borodighir Dhar Chandan Nagar, Hooghly, West Bengal, India

Date of Birth/Age :

24.09.1957

Date of Appointment :

14.06.1994

Email :

cs@eastindiapharma.org

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(As on 31.03.2007)

Category

 

Percentage

 

 

 

Bodies Corporate (Not mentioned above)

 

37.00

Directors or relatives of directors

 

14.00

Other top fifty (50)shareholders (other than listed above)

 

49.00

 

 

 

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Chemicals and Pharmaceuticals.

 

 

Products :

  • Manufacturing Drugs
  • Antacid and Antiflatulent
  • Antiamobebic
  • Antibacterial
  • Antibiotic
  • Anti filarial
  • Anti Fungal
  • Anti Inflammatory and Anti Fungal
  • Anti Inflammatory and Anti infective
  • Antiprotozoa
  • Antipyretic and Analgesic
  • Antiseptic
  • Antiviral
  • Anxiolytic
  • Digestive Enzyme
  • Haematinic
  • Hepatoprotective
  • Keratolytic and Fungicidal
  • Mucoevacuant and Bronchodilator
  • Nasal Decongestant
  • Vitamin – Mineral Tonic
  • Hepatoprotective
  • Mucoevacuant and Bronchodilator
  • Uterotrophic
  • Ophthalmic
  • Gastro-Prokinetic

 

 

GENERAL INFORMATION

 

Bankers :

  • United Bank of India,

53, Shyamaprasad Mukherjee Road, Kolkata – 700026, West Bengal, India

 

  • The Hongkong and Shanghai Banking Corporation

8, Netaji Shubhas Road, Kolkata – 700001, India

 

Banking Relations :

Satisfactory

 

 

Auditors :

 

Name :

Sukumar Bhattacharya

Chartered Accountant

 

 

Name :

A B Chaudhuri

Chartered Accountant

Address :

UM Chaudhuri and Company, 35-B, Lake Place, Kolkata – 700029, West Bengal, India

 

 

Subsidiaries :

Qasar Healthcare Private Limited

U99999WB1993PTC058605

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10000000

Equity Shares

Rs.10/- each

Rs.100.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

4450080

Equity Shares

Rs.10/- each

Rs.44.497 Millions

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2007

31.03.2006

31.03.2005

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

44.497

44.497

44.497

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

200.434

184.715

183.630

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

244.931

229.212

228.127

LOAN FUNDS

 

 

 

1] Secured Loans

143.659

129.938

111.193

2] Unsecured Loans

0.000

0.000

38.394

TOTAL BORROWING

143.659

129.938

149.587

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

388.590

359.150

377.714

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

132.582

69.884

69.149

Capital work-in-progress

4.353

11.851

0.935

 

 

 

 

INVESTMENT

0.240

0.240

0.243

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

184.151

198.862

192.265

 

Sundry Debtors

140.837

135.726

168.166

 

Cash & Bank Balances

50.581

71.979

57.395

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

41.811

44.579

30.646

Total Current Assets

417.380

451.146

448.472

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Current Liabilities

165.965

173.971

139.216

 

Provisions

0.000

0.000

6.073

Total Current Liabilities

165.965

173.971

145.289

Net Current Assets

251.415

277.175

303.183

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

Others

0.000

0.000

4.204

 

 

 

 

TOTAL

388.590

359.150

377.714

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2007

31.03.2006

31.03.2005

Debt Equity Ratio

(Total Liability/Networth)

 

1.26

1.32

1.29

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.51

2.59

3.09

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Form 8:

 

 

Corporate identity number (CIN) Foreign company registration number

U24231WB1936PTC008598

Name of the Company

EAST INDIA PHARMACEUTICAL WORKS LIMITED

Address

6 Little Russel Street, Kolkata – 700071, West Bengal, India

This form is for

Modification of Charge

Type of Charge

Immovable Property

Book Debts

Movable Property (not being pledge)

Others: Stocks

Particulars of the charge holder 

United Bank of India,

53, Shyam Prasad Mukherjee Road, Hazra Road Branch, Kolkata – 700026, West Bengal, India

homail@unitedbank.co.in

Nature or description of the instrument(s) creating or modifying the charge

By this Modification the overall limit has been enhanced to Rs.201.400 Millions in which UBI’s Share has been increase to Rs.169.900 Millions as cash credit Rs.76.500 Millions, Term Loan (I) Rs.23.100 Millions, LC (I and F) Rs.20.500 Millions, LG Rs.4.800 Millions, Term Loan (II) Rs.45.000 Millions and HSBC’s Share remains same Rs.31.500 Millions as Fund based Rs.18.500 Millions and Non Fund based Rs.13.000 Millions over Hypothecation of Stock, Book Debts, Plant and Machinery and Equitable Mortgage by Deposit of Title Deeds at Sarsuna PS Behala, 24 PGS South.

Date of the instrument creating or modifying the charge

31.03.2007

Amount secured by the charge

Rs.201.400 Millions

Brief particulars of the principal terms and conditions and extent and operation of the charge

Rate of Interests:

UBI’s Rate of Interests As:- Cash Credit at BPLR i.e. Presently 12.5% p.a. at monthly based subject to change from time to time. The interests shall have to be services as and when charged. Term Loan (I) 9.5% p.a. (Fixed) at monthly rest. The Interests shall have to be serviced as and when charged (No Charged). Term Loan (II) 9.5% at monthly rest with reset option after three years at a mutually agreed rate depending on the market Trend.

 

Terms of Repayments:

UBI’s Term Loan (I) As Existing Repayable In 11 More quarterly Installments of Rs.2.100 Millions each. With next installment due in September 06.

Term Loan (II) Repayable in 20 Equal Quarterly Installments of Rs.2.250 Millions each, Commission from June 2007 and Ending in March 2012

 

Margin:

UBI’s Stock 35%

Book Debts 50%

LC (I and F) Nil

LG Nil

100% for guarantee against disputed liabilities.

 

Extent and operation of the charge:

UBI’s Term Loan (II) Rs.4.500 Millions For Implementation of Phase (II) of Schedule of GMP Norms with project cost of around Rs.65.100 Millions

Short particulars of the property charged (including location of the property)

Stocks of Raw Materials as all kinds of patent medicines, Stocks of ampulses, book debts and Plant and machinery stored in to the premises at kolkata at sursuna, Behala, Pathakpara, Durgapur or where ever else and also mortgage by deposit of title deeds of immovable properties at sarsuna PS: Behala District 24 PGS (S).

Particular of the present modification 

The overall joint charge limit has been enhanced to Rs.1.400 Million in which UBI’s (Lead Bank) Share Increased to Rs.169.900 Millions As:- Cash Credit Rs.76.500 Millions, Term Loan (I) Rs.23.100 Millions, LC (I and F) Rs.20.500 Millions, LG Rs.4.800 Millions, Term Loan (II) Rs.45.000 Millions and HSBC’s Share Remains same Rs.31.500 Millions As Fund based Rs.18.500 Millions and Non Fund based Rs.13.000 Millions over hypothecation of stocks, book debts, Plant and Machinery and equitable mortgage by deposit of title deeds at sarsuna behala 24 PGS South.

 

 

Name of the company

EAST INDIA PHARMACEUTICAL WORKS LIMITED

Presented By

The Hongkong and Shanghai Banking Corporation

8 Netaji Subhas Road, Kolkata – 700001, India

1) Date and description of instrument creating the change

Unattested Joint Deed of Hypothecation over stocks end book debts dated 11 November, 1986

2) Amount secured by the charge/amount owing on the securities of charge

Rs.9.500 Millions

By the Hongkong and Shanghai Banking Corporation and Rs.20.135 Millions by United Bank of India

 

Aggregate overall limit of Rs.29.635 Millions

3) Short particular of the property charged. If the property acquired is subject to charge, date of the acquired of the property should be given

Company’s entire stocks of raw materials, stocks in- process, finished goods, store/ spares etc. at 119 Biren Ray Road, West, Kolkata

 

All Present and future Book Debts, Outstanding, bills, moneys receivable

4) Gist of the terms and conditions and extent and operation of the charge.

It is expressly agreed and warranted that the hypothecation of charge hereby constituted is and shall be a first charge and security over the said securities and no other charge any kind whether legal or equitable is or has been or shall be created.

 

Interests at the rate of 7.5% over Reserve Bank of India rate for advance to the schedule Banks against Government securities minimum 17.5% per annum on the daily balance should be charged provided however that the Bank shall at any time and from time to time be entitled to give notice of its intention to charge and may thereafter charge interests rates as the Bank may Specify.

5) Name and Address and description of the person entitled to the charge.

The Hongkong and Shanghai Banking Corporation

8, Netaji Shubhas Road, Kolkata – 700001, India

 

United Bank of India

53 Shyama Prasad, Mukherjee Road, Kolkata – 700026, India

6) Date  and brief description of instrument modifying the charge

NA

7) Particulars of modifications specifying the terms and conditions or the extent of operations of the charge in which modification is made and the details of the modification.

NA

 

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.40.02

UK Pound

1

Rs.79.44

Euro

1

Rs.62.94

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

8

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

8

--LEVERAGE

1~10

8

--RESERVES

1~10

8

--CREDIT LINES

1~10

7

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

63

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions